cGxP.wire https://validator.w3.org/feed/docs/rss2.html Kythera Labs Launches Clinical Semantic Bridge on Databricks Rhythm Publishes Phase 3 IMCIVREE Data in NEJM GeneCentric Launches ExpressCT Rewind to Unlock Gene Expression from Liquid Biopsy Data Arcutis FDA Accepts ZORYVE sNDA for Infant Dermatitis UroGen Announces FDA Clearance of IND for UGN-501 in Bladder Cancer 60 Degrees Pharma Expands Tick-Borne Disease Pipeline Genespire Reports Durable Preclinical Gene Therapy Results for Methylmalonic Acidemia Chemomab and Scipher Unite for AI-Powered Rheumatoid Arthritis Satellos Reports Positive Six-Month SAT-3247 Data OKYO Pharma Receives FDA Support for Phase 3 Trial Seres Therapeutics Reports Positive Early SER-155 Data Angelini Ventures Invests in Handspring Health Series B LTZ Therapeutics Receives FDA IND Clearance for LTZ-232 Nucleus Biologics Launches CRAIC Formulation Finder TaiMed Receives TFDA Notice for Trogarzo Insilico Begins Phase III Trial of AI-Designed IPF Therapy Vanda Gains FDA Rare Pediatric Designation for VCA-894A New England Biolabs Launches Direct RNA Sequencing Module WAVES Restores Emergency Veterinary Care in East Bay Revolution Medicines Advances Daraxonrasib Under EMA Review Teva Advances TEV-408 to Phase 2b for Vitiligo Alamar Biosciences Launches First Blood Test for eMTBR-Tau Evogene, Tel Aviv University Advance AI Drug Discovery OTR Therapeutics and LG Chem Partner to Advance Oncology Therapies Longeviti Launches AI-Powered Brain Ultrasound Interface Grünenthal Receives Dual FDA Designations for Tegacorat in DMD BioLineRx and Hemispherian Report Promising GLIX1 Ovarian Cancer Data Acumen to Present Alzheimer’s Research at AAIC 2026 Praxis and Remagine Collaborate on Ulixacaltamide Vaxart Reports Positive 12-Month Phase 2b Safety Data Aligos Secures $25M Upfront in Greater China Deal Grey Matters Receives First Brain-Dedicated PET Scanner Helix Expands Drug Discovery Collaboration with AstraZeneca Belite Bio Highlights DRAGON Trial at ISCEV and ASRS Cumulus and Muse Enhance CNS Clinical Trials Vivani Medical Partners with Novo Nordisk on NPM-139 Moleculin Reports Positive MIRACLE Trial Results Keenova Reports Positive Phase 3 Results for XIAFLEX Caristo Diagnostics Highlights AI Heart Imaging at SCCT 2026 Splash Beverage Acquires Global Rights to CannEpil Therapy Fate Therapeutics to Present FT819 Data at ISSCR 2026 Codis Expands European CDMO with Catalent Acquisition APDA Launches Mental Health Training for Parkinson’s Care Vivos Receives FDA IDE Approval for RadioGel Trial Healome Therapeutics Secures £2M to Advance Eye Drop Technology Insulet Expands Omnipod 5 Diabetes Care in Spain Ionis Reaches Phase 3 Enrollment Milestone for Obudanersen Regal Healthcare Capital Closes $610 Million Fund IV Curis Achieves Early Enrollment in Phase 2 CLL Trial RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing